Validation of a risk assessment instrument for pulmonary arterial hypertension

Jason Weatherald^{1

2

3

4}, Olivier Sitbon^{2

3

4}, Marc Humbert^{2

3

4}

Affiliations

¹ University of Calgary Cumming School of Medicine, Department of Medicine, Division of Respirology, Calgary, Alberta, Canada.
² Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
³ Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
⁴ INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Editorial

Jason Weatherald et al. Eur Heart J. 2018.

. 2018 Dec 14;39(47):4182-4185.

doi: 10.1093/eurheartj/ehx301.

Jason Weatherald^{1

2

3

4}, Olivier Sitbon^{2

3

4}, Marc Humbert^{2

3

4}

¹ University of Calgary Cumming School of Medicine, Department of Medicine, Division of Respirology, Calgary, Alberta, Canada.
² Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
³ Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
⁴ INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

No abstract available

Comment on

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
Kylhammar D, Kjellström B, Hjalmarsson C, Jansson K, Nisell M, Söderberg S, Wikström G, Rådegran G. Kylhammar D, et al. Eur Heart J. 2018 Dec 14;39(47):4175-4181. doi: 10.1093/eurheartj/ehx257. Eur Heart J. 2018. PMID: 28575277